In Moderate to severe pain T Dol 37.5mg/325mg Tablet effectively relieves moderate to severe pain in conditions like menstrual cramp, arthritis, headache, muscle aches if taken when the first signs of pain occur. It works by reducing substances in the body that causes pain. This gives relief from pain and discomfort and thus improves the quality of your life. Take T Dol 37.5mg/325mg Tablet by mouth as directed by your doctor.
It is unsafe to consume alcohol with T Dol 37.5mg/325mg Tablet.
T Dol 37.5mg/325mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
T Dol 37.5mg/325mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Consult a doctor immediately if the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing problems, or limpness.
T Dol 37.5mg/325mg Tablet may cause side effects which could affect your ability to drive.
T Dol 37.5mg/325mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of T Dol 37.5mg/325mg Tablet may be needed. Please consult your doctor.
T Dol 37.5mg/325mg Tablet should be used with caution in patients with liver disease. Dose adjustment of T Dol 37.5mg/325mg Tablet may be needed. Please consult your doctor. However, the use of T Dol 37.5mg/325mg Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of T Dol 37.5mg/325mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Novogen Captab || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Merril Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vintek Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fulfil Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nuwill Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Reltic Labs || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Themis Medicare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Laclin Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vinson pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Accuminn Labs || ₹14.5/tablet (25% cheaper)